Breast Mesh & "Internal Bra" Complications

Breast mesh or "internal bra" lawsuits involve surgical mesh products used in breast reconstruction, augmentation, lift, and revision procedures to provide internal support to breast tissue or implants. These synthetic or biologic mesh materials were originally cleared for soft‑tissue reinforcement in other parts of the body but were never specifically approved by the FDA for use in breast surgeries, even though manufacturers promoted them for that purpose.

Across the country, women are bringing claims that these mesh devices were defectively designed, inadequately tested for long‑term safety in breast tissue, and sold without proper warnings about the risk of serious complications such as infection, mesh migration, tissue necrosis, and the need for additional surgeries. Many suits allege that manufacturers aggressively marketed mesh as an "internal bra" solution despite FDA communications clarifying that the safety and effectiveness of surgical mesh in breast surgery has not been established.